SCP VITALIFE PARTNERS
SCP Vitalife is a Life Sciences Fund formed by SCP Partners , a U.S.-based investment organization with over $900 million in venture funds under management, and Vitalife , an experienced venture firm investing primarily in Israeli medical technology companies. The SCP Vitalife team includes investment professionals with prior experiences as senior executives, clinical practitioners and venture capitalists. Their focus is on early to mid-stage life science technologies and services, with a co... ncentration on therapeutic medical devices. They will continue to follow the successful formula of their predecessor fund, Vitalife Life Sciences Fund, offering their portfolio companies hands-on strategic assistance in planning, operations and finance. From their investment experience they have developed extensive networks to access capital, recruit management and facilitate favorable strategic alliances.
SCP VITALIFE PARTNERS
Social Links:
Industry:
Life Science Medical Device Pharmaceutical
Founded:
2002-01-01
Status:
Active
Contact:
(610) 975-9546
Email Addresses:
[email protected]
Technology used in webpage:
SPF Apache Microsoft Exchange Online Office 365 Mail Google Maps Microsoft Azure DNS PHP Sectigo SSL Sectigo Domain SSL OpenResty
Current Employees Featured
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2016-02-07 | Regentis Biomaterials | SCP Vitalife Partners investment in Series D - Regentis Biomaterials | 15 M USD |
2015-09-01 | Ivenix | SCP Vitalife Partners investment in Venture Round - Ivenix | 42 M USD |
2015-07-01 | MST Medical Surgery Technologies | SCP Vitalife Partners investment in Series C - MST Medical Surgery Technologies | 12.5 M USD |
2013-11-11 | Sensible Medical Innovations | SCP Vitalife Partners investment in Venture Round - Sensible Medical Innovations | 20 M USD |
2013-06-17 | Rewalk Robotics | SCP Vitalife Partners investment in Series D - Rewalk Robotics | 1.2 M USD |
2013-03-05 | Avedro | SCP Vitalife Partners investment in Series D - Avedro | 43 M USD |
2012-05-14 | Regentis Biomaterials | SCP Vitalife Partners investment in Series C - Regentis Biomaterials | 10 M USD |
2012-02-21 | Avedro | SCP Vitalife Partners investment in Venture Round - Avedro | 500 K USD |
2011-08-16 | Fluidnet | SCP Vitalife Partners investment in Series C - Fluidnet | 25 M USD |
2011-07-07 | Avedro | SCP Vitalife Partners investment in Series C - Avedro | 25 M USD |